Search Result "PD-1/PD-L1inhibitors."


Review Article

Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives

Journal: Current Drug Metabolism
Volume: 18 Issue: 8 Year: 2017 Page: 700-711
Author(s): Steven A. Mann,Antonio Lopez-Beltran,Francesco Massari,Roberto Pili,Michelangelo Fiorentino,Michael O. Koch,Hristos Z. Kaimakliotis,Lisha Wang,Marina Scarpelli,Chiara Ciccarese,Holger Moch,Rodolfo Montironi,Liang Cheng

Review Article

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 2 Year: 2019 Page: 100-112
Author(s): Spandana R. Kopalli,Tae-Bong Kang,Kwang-Ho Lee,Sushruta Koppula

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

Journal: Current Drug Safety
Volume: 11 Issue: 1 Year: 2016 Page: 62-68
Author(s): Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello, Cesare Gridelli

General Review Article

Immunotherapy and Radiation Therapy in Renal Cell Carcinoma

Journal: Current Drug Targets
Volume: 21 Issue: 14 Year: 2020 Page: 1463-1475
Author(s): Veronica Mollica,Matteo Santoni,Vincenzo Di Nunno,Alessia Cimadamore,Liang Cheng,Antonio Lopez-Beltran,Nicola Battelli,Rodolfo Montironi,Francesco Massari

Review Article

Research Progress of PD 1/PD L1 Inhibitors in the Treatment ofUrological Tumors

Journal: Current Cancer Drug Targets
Volume: 24 Issue: 11 Year: 2024 Page: 1104-1115
Author(s):

Review Article

Cisplatin-Based Combination Therapy for Enhanced Cancer Treatment

Journal: Current Drug Targets
Volume: 25 Issue: 7 Year: 2024 Page: 473-491
Author(s):

Results 1 - 1 of 6

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy